Search clinical trials for: 0.1cc HBVAXPRO 40mcgr/ml (Sanofi Pasteur MSD)

Total 7 results

Novosanis NV

Completed

Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-ID (POC_VAX-ID)

Hepatitis B

Belgium
University of Oxford

Completed

New Methods to Measure the Immune Response to Hepatitis B Vaccine

Hepatitis B

United Kingdom
ANRS, Emerging Infectious Diseases
MCM Vaccines B.V.

Completed

Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients (VIHVAC-B)

HIV Infections

France
ANRS, Emerging Infectious Diseases
MCM Vaccines B.V.

Completed

Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST) (B-BOOST)

HIV Infection | Hepatitis B

France
Universitaire Ziekenhuizen KU Leuven
KU Leuven

Unknown

Polysaccharide Antibody Response Study (PARS)

Specific Polysaccharide Antibody Deficiency

Belgium
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

Measles; Mumps; Rubella | Measles-Mumps-Rubella Vaccine

United States, Finland, Taiwan, Estonia, Puerto Rico
University of Oxford

Completed

A Study of the Interaction Between BCG And MenC Immunisation: BAM (BAM)

Immune Response | BCG Infection | Reaction - Vaccine

United Kingdom

3

Subscribe